Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NAT-TENOFOVIR DIN 02472511

Status: Marketed
Holder: NATCO PHARMA (CANADA) INC
Molecule: TENOFOVIR DISOPROXIL FUMARATE

Health Canada record

Active ingredient(s)TENOFOVIR DISOPROXIL FUMARATE 300 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCJ05AF07 TENOFOVIR DISOPROXIL
Original market date15-Mar-2018
Current status date15-Mar-2018
SourceHealth Canada DPD

Establishment licence of the holder

Natco Pharma (Canada) Inc — licence 102058, currently licensed, last inspection rating C (2022-07-26).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TENOFOVIR DISOPROXIL FUMARATE

DINProductCompanyFormStrengthStatus
02516276AG-TENOFOVIRANGITA PHARMA INC.TabletTENOFOVIR DISOPROXIL FUMARATE 300 MGMarketed
02451980APO-TENOFOVIRAPOTEX INCTabletTENOFOVIR DISOPROXIL FUMARATE 300 MGMarketed
02460173AURO-TENOFOVIRAURO PHARMA INCTabletTENOFOVIR DISOPROXIL FUMARATE 300 MGMarketed
02479087JAMP-TENOFOVIRJAMP PHARMA CORPORATIONTabletTENOFOVIR DISOPROXIL FUMARATE 300 MGMarketed
02512939MINT-TENOFOVIRMINT PHARMACEUTICALS INCTabletTENOFOVIR DISOPROXIL FUMARATE 300 MGMarketed
02452634MYLAN-TENOFOVIR DISOPROXILMYLAN PHARMACEUTICALS ULCTabletTENOFOVIR DISOPROXIL FUMARATE 300 MGMarketed
02453940PMS-TENOFOVIRPHARMASCIENCE INCTabletTENOFOVIR DISOPROXIL FUMARATE 300 MGMarketed
02515156RIVA-TENOFOVIRLABORATOIRE RIVA INC.TabletTENOFOVIR DISOPROXIL FUMARATE 300 MGMarketed
02523922TENOFOVIRSIVEM PHARMACEUTICALS ULCTabletTENOFOVIR DISOPROXIL FUMARATE 300 MGMarketed
02512327TENOFOVIRSANIS HEALTH INCTabletTENOFOVIR DISOPROXIL FUMARATE 300 MGMarketed
02403889TEVA-TENOFOVIRTEVA CANADA LIMITEDTabletTENOFOVIR DISOPROXIL FUMARATE 300 MGMarketed
02247128VIREADGILEAD SCIENCES CANADA INCTabletTENOFOVIR DISOPROXIL FUMARATE 300 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
264012021-08-10Supplement to an Abbreviated New Drug Submission (SANDS)Updates to labelling material
206222018-03-15Abbreviated New Drug Submission (ANDS)

International API supply for TENOFOVIR DISOPROXIL FUMARATE

26 active FDA Drug Master Files.

Request a quote for NAT-TENOFOVIR

How to read a Canadian DIN record